Evidence map›Paper›PMID 33093265›Full record

ArticleBiomolecules & therapeutics2021

Contributions of HO-1-Dependent MAPK to Regulating Intestinal Barrier Disruption.

Zhenling Zhang, Qiuping Zhang, Fang Li, Yi Xin, Zhijun Duan

Open access · greenAbstract read
In one paragraph

Article in Biomolecules & therapeutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Frontiers in pharmacology · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. IL-22-ActivatedCells · 2023
    Article
  11. Review
  12. Article
  13. Article
  14. Frontiers in pharmacology · 2022
    Article
  15. Dynamics of the gut-liver axis in rats with varying fibrosis severity.International journal of biological sciences · 2022
    Article
  16. Article
  17. HO-1/CO Maintains Intestinal Barrier Integrity through NF-Oxidative medicine and cellular longevity · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Zhenling ZhangDepartment of Gastroenterology, the First Affiliated Hospital of Dalian Medical University, Dalian116011, China.
Qiuping ZhangDepartment of Pathology, the First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.
Fang LiDepartment of Immunology, Dalian Medical University, Dalian 116044, China.
Yi XinDepartment of Biochemistry and Molecular Biology, Dalian Medical University, Dalian 116044, China.
Zhijun DuanDepartment of Gastroenterology, the First Affiliated Hospital of Dalian Medical University, Dalian116011, China.
Dalian Medical University · CNFirst Affiliated Hospital of Dalian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The mitogen-activated protein kinase (MAPK) pathway controls intestinal epithelial barrier permeability by regulating tight junctions (TJs) and epithelial cells damage. Heme oxygenase-1 (HO-1) and carbon monoxide (CO) protect the intestinal epithelial barrier function, but the molecular mechanism is not yet clarified. MAPK activation and barrier permeability were studied using monolayers of Caco-2 cells treated with tissue necrosis factor α (TNF-α) transfected with FUGW-HO-1 or pLKO.1-sh-HO-1 plasmid. Intestinal mucosal barrier permeability and MAPK activation were also investigated using carbon tetrachloride (CCl

Indexed as

HO-1Inflammatory bowel diseaseIntestinal barrier functionMAPKTight junction

Identifiers

PMID33093265
PMCPMC7921856
OpenAlexW3094124965

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.